| Home : March 2022 : March 14, 2022 News : Impact Therapeutics Announces Completion of Series D1 Financing |
Impact Therapeutics Announces Completion of Series D1 Financing |
March 14, 2022
SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated to the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality, announced the successful completion of its Series D1 financing. Institutional investors...
http://prnmedia.prnewswire.com/news-releases/impact-therapeutics-announces-completion-of-series-d1-financing-301501583.html
|
|
|
 Other Stories |
|
|
|
|
|
|
|
|
|
|
|
